CLINICAL CHARACTERISTICS AND LABORATORY FINDINGS OF ISCHEMIC HEART DISEASE IN THE PRESENCE OF MULTIPLE COMORBIDITIES

Authors

  • Akhmedov A.T. PhD., Associate Professor, Pediatric Surgery and Neurosurgery, Bukhara State Medical Institute, Bukhara, 200100, Uzbekistan Автор
  • Akhrorov J.Kh. Interventional cardiologists, CathLab, Bukhara Branch of Republican Research Centre Of Emergency Medicine, Bukhara, 200100, Uzbekistan Автор

DOI:

https://doi.org/10.5281/zenodo.17292078

Keywords:

In this context, it is essential to investigate the role of demographic, regional, and anthropometric factors in the development and course of AH and IHD.

Abstract

Cardiovascular diseases (CVD) remain the leading causes of global mortality, annually claiming the lives of more than 18 million people [1,2]. Arterial hypertension (AH) and ischemic heart disease (IHD) are the main determinants of critical vascular complications. According to global statistics [3], AH affects more than 1.2 billion people, while IHD is diagnosed in over 120 million. The coexistence of these pathologies is especially common in individuals over 60 years of age, reaching up to 50%, which is linked to excess body weight, lipid metabolism disorders, and chronic inflammation [4,5]..

References

1.A.T. Akhmedov (2024). IMPACT OF CYTOKINES ON THE ONSET AND PROGRESSION OF ARTERIAL HYPERTENSION. Eurasian Journal of Medical and Natural Sciences, 4 (6), 116-123. doi: 10.5281/zenodo.12154505.

2.Akhmedov, A. T., & Sharipov, Z. R. (2023). The role of cytokines in the development of arterial hypertension. Int J Med Sci Clin Res, 3(03), 59-67.

3.GBD 2021 Hypertension Collaborators. (2023). Global, regional, and national burden of hypertension, 1990–2021. The Lancet, 402(10397), 820–835.

4.Libby, P., & Ridker, P. M. (2022). Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Circulation Research, 131(2), 147–160.

5.Roth, G. A., Mensah, G. A., & Johnson, C. O. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2982–3021.

6.Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., ... & Tsao, C. W. (2021). Heart disease and stroke statistics—2021 update: a report from the American Heart Association. Circulation, 143(8), e254–e743.

7.Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Himmelfarb, C. D., ... & Wright, J. T. (2018). 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Journal of the American College of Cardiology, 71(19), e127–e248.

8.Williams, B., Mancia, G., Spiering, W., Rosei, E. A., Azizi, M., Burnier, M., ... & Coca, A. (2018). 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 39(33), 3021–3104.

9.World Health Organization. (2023). Cardiovascular diseases (CVDs) fact sheet. WHO.

Downloads

Published

2025-10-07

Issue

Vol. 1 No. 1 (2025): International Conference on Science, Education & Law

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

By submitting a paper to the conference organized by Academic Publishing House, the author(s) agree to the following license terms and conditions:

1. Copyright and Licensing

  1. The author(s) retain the copyright of their article.

  2. The author(s) grant Academic Publishing House a non-exclusive license to publish, distribute, and archive the submitted material in both electronic and print formats.

  3. The work will be published under the Creative Commons Attribution (CC BY 4.0) license, allowing others to share and adapt the material for any purpose, provided proper credit is given to the original author(s).

2. Author’s Responsibilities

  1. The author(s) guarantee that the submitted work is original, does not infringe any existing copyrights, and has not been published or submitted elsewhere.

  2. The author(s) confirm that all co-authors have approved the final version of the manuscript and agree with its submission and publication.

  3. The author(s) are fully responsible for the accuracy of the data, citations, and references provided in the article.

3. Publisher’s Rights

  1. Academic Publishing House reserves the right to edit, format, and make minor grammatical or layout corrections to the paper without altering its core content.

  2. The publisher has the right to include the article in indexing databases, archives, and repositories such as Google Scholar, Zenodo, OpenAIRE, and other partner platforms.

  3. The publisher may promote the paper through its website and official social media channels.

4. Open Access Policy

All conference papers are published as open access, ensuring free and permanent online access to the full text of all articles immediately upon publication.

5. Withdrawal and Retraction

If ethical misconduct, plagiarism, or data manipulation is detected, Academic Publishing House reserves the right to withdraw or retract the publication at any stage.

6. Acceptance of Terms

Submission of a manuscript to the conference implies that the author(s) have read, understood, and accepted these License Terms.

How to Cite

Akhmedov, A., & Akhrorov, J. (2025). CLINICAL CHARACTERISTICS AND LABORATORY FINDINGS OF ISCHEMIC HEART DISEASE IN THE PRESENCE OF MULTIPLE COMORBIDITIES . International Conference on Science, Education & Law, 1(1), 39-41. https://doi.org/10.5281/zenodo.17292078